A.P. Møller - Mærsk A/S
28.9.2026 13:54:47 CEST | Globenewswire | Press release
Transactions in connection with share buy-back program
Transactions in connection with share buy-back program
ANNOUNCEMENT
A.P. Møller - Mærsk A/S – Transactions in connection with share buy-back program
On 5 February 2026, A.P. Møller - Mærsk A/S (the “Company”) announced a share buy-back program of up to DKK 6.3bn (around USD 1bn) to be executed over a period of 12 months. The second phase of the share buy-back program will run from 13 August 2026 up to 29 January 2027. The shares to be acquired will be limited to a total market value of DKK 3.15 billion (around USD 500m).
The share buy-back program will be executed under EU Commission Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the “Safe Harbour Regulation”).
The following transactions have been made under the program in the period 21 September to 25 September 2026:
| Number of A shares | Average purchase price A shares, DKK | Transaction value, A shares, DKK | |
| Accumulated, last announcement | 45,448 | 753,771,360 | |
| 21 September 2026 | 250 | 22,539.2800 | 5,634,820 |
| 22 September 2026 | 250 | 22,324.8000 | 5,581,200 |
| 23 September 2026 | 250 | 22,072.8800 | 5,518,220 |
| 24 September 2026 | 250 | 22,721.3600 | 5,680,340 |
| 25 September 2026 | 250 | 22,561.2000 | 5,640,300 |
| Total 21-25 September 2026 | 1,250 | 28,054,880 | |
| Accumulated in the second phase of the program | 8,450 | 179,471,870 | |
| Accumulated under the program | 46,698 | 781,826,240 | |
| Number of B shares | Average purchase price B shares, DKK | Transaction value, B shares, DKK | |
| Accumulated, last announcement (market and the Foundation) | 181,792 | 3,086,785,999 | |
| 21 September 2026 | 877 | 23,350.7298 | 20,478,590 |
| 22 September 2026 | 877 | 23,154.4242 | 20,306,430 |
| 23 September 2026 | 877 | 22,849.9202 | 20,039,380 |
| 24 September 2026 | 877 | 23,602.6226 | 20,699,500 |
| 25 September 2026 | 877 | 23,440.1254 | 20,556,990 |
| Total 21-25 September 2026 | 4,385 | 102,080,890 | |
| Bought from the Foundation* | 615 | 23,279.5644 | 14,316,932 |
| Accumulated in the second phase of the program (market and the Foundation) | 33,800 | 745,315,547 | |
| Accumulated under the program (market and the Foundation) | 186,792 | 3,203,183,822 |
*) According to a separate agreement, A.P. Møller og Hustru Chastine Mc-Kinney Møllers Familiefond (the Foundation) participates on a pro rata basis to the shares purchased in the share buy-back program.
With the transactions stated above, the Company owns a total of 46,698 A shares and 246,430 B shares as treasury shares, corresponding to 1.99% of the share capital. Details of each transaction are included as appendix.
Copenhagen, 28 September 2026
Contact persons:
Head of Investor Relations, Martin Dunwoodie, tel. +45 3363 3484
Head of Media Relations, Jesper Lov, tel. +45 6114 1521
Page 1 of 1
Attachments
- Announcement - Transactions in connection with share buy-back program - week 39 2026
- Daily transactions in connection with share buy-back program - week 39 2026
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Golar LNG7.10.2026 15:20:44 CEST | Press release
Golar LNG acquires conversion vessel for 4th FLNG
Danske Bank A/S7.10.2026 15:08:48 CEST | Press release
Danske Bank A/S, transactions by persons discharging managerial responsibilities
Danske Bank A/S7.10.2026 15:08:48 CEST | Pressemeddelelse
Danske Bank A/S, ledende medarbejderes transaktioner
HMS Networks AB7.10.2026 14:31:41 CEST | Press release
Invitation to HMS Networks’ third quarter conference call 2026
Cyllene Therapeutics7.10.2026 14:30:00 CEST | Press release
Cyllene Therapeutics Presents Interim Data from Phase 1b/2a Clinical Trial Showing EG110A Reduced Urinary Episodes in Patients with Spinal Cord Injury at the International Continence Society (ICS) Conference
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom